227 related articles for article (PubMed ID: 9613625)
1. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters.
O'Donnell P; Grace AA
Schizophr Bull; 1998; 24(2):267-83. PubMed ID: 9613625
[TBL] [Abstract][Full Text] [Related]
2. Integrating schizophrenia.
Gray JA
Schizophr Bull; 1998; 24(2):249-66. PubMed ID: 9613624
[TBL] [Abstract][Full Text] [Related]
3. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
Swerdlow NR; Geyer MA
Schizophr Bull; 1998; 24(2):285-301. PubMed ID: 9613626
[TBL] [Abstract][Full Text] [Related]
4. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia.
Csernansky JG; Bardgett ME
Schizophr Bull; 1998; 24(2):231-48. PubMed ID: 9613623
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic responses in the core part of the nucleus accumbens to subcutaneous MK801 administration are increased following postnatal transient blockade of the prefrontal cortex.
Tagliabue E; Pouvreau T; Eybrard S; Meyer F; Louilot A
Behav Brain Res; 2017 Sep; 335():191-198. PubMed ID: 28823626
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-dopamine interaction and its relevance to schizophrenia.
Kapur S; Remington G
Am J Psychiatry; 1996 Apr; 153(4):466-76. PubMed ID: 8599393
[TBL] [Abstract][Full Text] [Related]
7. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
8. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.
Joyce JN
Psychopharmacology (Berl); 1993; 112(1 Suppl):S16-34. PubMed ID: 7831438
[TBL] [Abstract][Full Text] [Related]
9. Altered prefrontal cortex-nucleus accumbens information processing in a developmental animal model of schizophrenia.
Goto Y; O'Donnell P
Ann N Y Acad Sci; 2003 Nov; 1003():398-401. PubMed ID: 14684471
[No Abstract] [Full Text] [Related]
10. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
Jentsch JD; Roth RH; Taylor JR
Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
[TBL] [Abstract][Full Text] [Related]
11. [Schizophrenia: a psychobiological view].
Rodríguez-Arias M; Aguilar MA; Espert R; Miñarro J
Rev Neurol; 1996 Oct; 24(134):1210-20. PubMed ID: 8983716
[TBL] [Abstract][Full Text] [Related]
12. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?
Andreasen NC; Paradiso S; O'Leary DS
Schizophr Bull; 1998; 24(2):203-18. PubMed ID: 9613621
[TBL] [Abstract][Full Text] [Related]
13. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving.
Heinz A; Siessmeier T; Wrase J; Hermann D; Klein S; Grüsser SM; Flor H; Braus DF; Buchholz HG; Gründer G; Schreckenberger M; Smolka MN; Rösch F; Mann K; Bartenstein P
Am J Psychiatry; 2004 Oct; 161(10):1783-9. PubMed ID: 15465974
[TBL] [Abstract][Full Text] [Related]
14. Neural circuits engaged in ventral hippocampal modulation of dopamine function in medial prefrontal cortex and ventral striatum.
Taepavarapruk P; Howland JG; Ahn S; Phillips AG
Brain Struct Funct; 2008 Sep; 213(1-2):183-95. PubMed ID: 18288486
[TBL] [Abstract][Full Text] [Related]
15. Abnormal neural integration related to cognition in schizophrenia.
Dolan RJ; Fletcher PC; McKenna P; Friston KJ; Frith CD
Acta Psychiatr Scand Suppl; 1999; 395():58-67. PubMed ID: 10225334
[TBL] [Abstract][Full Text] [Related]
16. Pathology, phenomenology and the dopamine hypothesis of schizophrenia.
McKenna PJ
Br J Psychiatry; 1987 Sep; 151():288-301. PubMed ID: 3322465
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
Marek GJ
Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
[TBL] [Abstract][Full Text] [Related]
18. The ventral portion of the CA1 region of the hippocampus and the prefrontal cortex as candidate regions for neuromodulation in schizophrenia.
Ewing SG; Winter C
Med Hypotheses; 2013 Jun; 80(6):827-32. PubMed ID: 23583328
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia, psychosis, and the basal ganglia.
Busatto GF; Kerwin RW
Psychiatr Clin North Am; 1997 Dec; 20(4):897-910. PubMed ID: 9443356
[TBL] [Abstract][Full Text] [Related]
20. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Masana M; Bortolozzi A; Artigas F
Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
